Ketek and Face oedema - a phase IV clinical study of FDA data

Summary:

Face oedema is reported as a side effect among people who take Ketek (telithromycin), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Claritin, and have Pharyngitis.

The phase IV clinical study analyzes which people have Face oedema when taking Ketek. It is created by eHealthMe based on reports of 4,619 people who have side effects when taking Ketek from the FDA, and is updated regularly.

What is Ketek?

Ketek has active ingredients of telithromycin. eHealthMe is studying from 4,631 Ketek users. Check the latest studies of Ketek.

What is Face oedema?

Face oedema (swelling of face) is found to be associated with 1,322 drugs and 2,110 conditions by eHealthMe. Check the latest studies of Face oedema.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 29, 2026

4,619 people reported to have side effects when taking Ketek.
Among them, 27 people (0.58%) have Face oedema.

Among these 27 people:

How long have people been on Ketek when they have Face oedema? *

What is the gender of people who have Face oedema when taking Ketek? *

female: 85.19 %
male: 14.81 %

What is the age of people who have Face oedema when taking Ketek? *

What are other drugs people take besides Ketek? *

What are other side effects people have besides Face oedema? *

Erythema Multiforme (a type of hypersensitivity reaction): 14 people, 51.85%
White Blood Cell Count Increased: 13 people, 48.15%
Blood Glucose Increased: 13 people, 48.15%
Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 13 people, 48.15%
Cerebral Ischaemia (insufficient blood flow to the brain to meet metabolic demand): 13 people, 48.15%
Oesophagitis (inflammation of oesophagus): 13 people, 48.15%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 13 people, 48.15%
Sepsis (a severe blood infection that can lead to organ failure and death): 13 people, 48.15%
Septic Shock (shock due to blood infection): 13 people, 48.15%
Skin Discoloration - Bluish (bluish colour of skin): 13 people, 48.15%

What are the existing conditions these people have? *

Pharyngitis (inflammation of the pharynx, causing a sore throat): 13 people, 48.15%
Pain: 7 people, 25.93%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 5 people, 18.52%
Sinusitis (inflammation of sinus): 4 people, 14.81%
Upper Respiratory Tract Inflammation: 1 person, 3.70%
Upper Respiratory Tract Infection Bacterial: 1 person, 3.70%
Pneumonia: 1 person, 3.70%
Nasopharyngitis (inflammation of the nasopharynx): 1 person, 3.70%
Itching: 1 person, 3.70%
High Blood Pressure: 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Ketek and have Face oedema?

- Check whether Face oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ketek:

Ketek (4,631 reports)

Face oedema treatments and more:

Face oedema (29,111 reports)

Browse all side effects of Ketek:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Face oedema:

Face oedema (1,322 drugs)

Browse all the conditions that are associated with Face oedema:

Face oedema (2,110 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on telithromycin (the active ingredients of Ketek) and Ketek (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.